Funding for this research was provided by:
Received: 16 August 2021
Accepted: 4 September 2021
First Online: 17 September 2021
: The study protocol was approved by the institutional review board (20032604-IRB01).
: Dr. Kaur disclose research funding from American Association of Respiratory Care. Dr. Vines discloses research funding from Teleflex Medical, Inc. and Rice Foundation, and speaker fees from Theravance Biopharma. Dr. Scott declares to receive research funding from Teleflex. Dr. Trump discloses consulting fees from Fisher and Paykel. Dr. Li discloses research funding from Fisher & Paykel Healthcare Ltd, Aerogen Ltd, and Rice Foundation, and speaker fees from American Association for Respiratory Care, Aerogen Ltd, and Fisher & Paykel Healthcare Ltd. Other authors have no conflict of interest to disclose.